共 63 条
[1]
Hale M.E.(1999)Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain Clin J Pain 15 179-183
[2]
Fleischmann R.(2005)Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study J Pain 6 21-28
[3]
Salzman R.(2007)A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain Curr Med Res Opin 23 117-128
[4]
Hale M.E.(2007)Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study Clin J Pain 23 287-299
[5]
Dvergsten C.(2006)The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain J Opioid Manag 2 155-166
[6]
Gimbel J.(2007)Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis Clin Ther 29 874-888
[7]
Katz N.(2005)Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial Pain Med 6 357-366
[8]
Rauck R.(2000)Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation Arch Intern Med 160 853-860
[9]
Ahdieh H.(2004)Opioids in chronic non-cancer pain: systematic review of efficacy and safety Pain 112 372-380
[10]
Portenoy R.K.(2008)Opioid complications and side effects Pain Physician 11 S105-S120